Injectable polypeptide-polysaccharide depot for preventing postoperative tumor recurrence by concurrent in situ chemotherapy and brachytherapy
Open Access
- 27 August 2024
- journal article
- research article
- Published by Elsevier in Materials Today Bio
- Vol. 28, 101219
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 40 references indexed in Scilit:
- Recent progress in quantitative analysis of self‐assembled peptidesExploration, 2024
- Clinical application of 99mTc‐labeled peptides for tumor imaging: Current status and future directionsiRADIOLOGY, 2024
- Clinical Care for People Who Survive Childhood CancerJAMA, 2023
- An in situ self‐assembled peptide derivative for inhibition of glutathione synthesis and selective enhancement of tumor radiotherapyiRADIOLOGY, 2023
- Gel/hydrogel‐based in situ biomaterial platforms for cancer postoperative treatment and recoveryExploration, 2023
- Supramolecular Nitric Oxide Depot for Hypoxic Tumor Vessel Normalization and RadiosensitizationAdvanced Materials, 2022
- A dynamic covalent polymeric antimicrobial for conquering drug‐resistant bacterial infectionExploration, 2022
- Development of injectable thermosensitive polypeptide hydrogel as facile radioisotope and radiosensitizer hotspot for synergistic brachytherapyActa Biomaterialia, 2020
- Kidney‐sparing whole abdominal irradiation in Wilms tumor: Potential advantages of VMAT techniquePediatric Blood & Cancer, 2020
- The comparative clinical pharmacology of vincristine and vindesine: Does vindesine offer any advantage in clinical use?Cancer Treatment Reviews, 1995